Premium
Disrupting Virchow's triad: can factor X inhibition reduce risk of adverse outcomes in patients with ischaemic cardiomyopathy?
Author(s) -
Ahmad Tariq,
Butler Javed
Publication year - 2015
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.296
Subject(s) - medicine , heart failure , rivaroxaban , stroke (engine) , cardiology , myocardial infarction , adverse effect , population , intensive care medicine , thrombus , clotting factor , cardiomyopathy , warfarin , atrial fibrillation , mechanical engineering , environmental health , engineering